EUVIMEDEUVIMED entdecken
Crossref

Biosimilar medical products: What a physician needs to know

The Internet Journal of Family Practice · 2010

DOI: 10.5580/194a ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Internet Journal of Family Practice, 2010. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first generation of approved biopharmaceuticals was developed a few decades ago. Drugs such as insulin, growth hormone, erythroprotein and cytokines were manufactured using recombinant DNA (rDNA) technology or hybridoma methods. They have improved the lives of countless patients of diabetes, short stature, anaemia, cancer, multiple sclerosis and hepatitis. Patents for many of these firstgeneration biotechnology products have, or are soon going to, expire. In many parts of world , strict patent laws are not in force. This has led to the development of various ‘copies” of these molecules by drug manufacturers. These products are known as biosimilars.

Zitieren

APA

(2010). Biosimilar medical products: What a physician needs to know. The Internet Journal of Family Practice. https://doi.org/10.5580/194a

Vancouver

Biosimilar medical products: What a physician needs to know. The Internet Journal of Family Practice. 2010. doi:10.5580/194a

BibTeX
@article{euvimed2010,
  title = {Biosimilar medical products: What a physician needs to know},
  journal = {The Internet Journal of Family Practice},
  year = {2010},
  doi = {10.5580/194a}
}
Kostenlos starten →